These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8221168)

  • 21. Pressor, tachycardic and behavioral excitatory responses in conscious rats following ICV administration of ACTH and CRF are blocked by naloxone pretreatment.
    Saunders WS; Thornhill JA
    Peptides; 1986; 7(4):597-601. PubMed ID: 3020526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delayed satiety-like actions and altered feeding microstructure by a selective type 2 corticotropin-releasing factor agonist in rats: intra-hypothalamic urocortin 3 administration reduces food intake by prolonging the post-meal interval.
    Fekete EM; Inoue K; Zhao Y; Rivier JE; Vale WW; Szücs A; Koob GF; Zorrilla EP
    Neuropsychopharmacology; 2007 May; 32(5):1052-68. PubMed ID: 17019404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endogenous corticotropin-releasing factor modulates feeding induced by neuropeptide Y or a tail-pinch stressor.
    Heinrichs SC; Cole BJ; Pich EM; Menzaghi F; Koob GF; Hauger RL
    Peptides; 1992; 13(5):879-84. PubMed ID: 1480513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alpha-helical CRF(9-41) prevents anxiogenic-like effect of NPY Y1 receptor antagonist BIBP3226 in rats.
    Kask A; Rägo L; Harro J
    Neuroreport; 1997 Nov; 8(16):3645-7. PubMed ID: 9427342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of corticotropin-releasing factor on food intake and brown adipose tissue thermogenesis in rats.
    Arase K; York DA; Shimizu H; Shargill N; Bray GA
    Am J Physiol; 1988 Sep; 255(3 Pt 1):E255-9. PubMed ID: 3262311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of noise on high-affinity choline uptake in the frontal cortex and hippocampus of the rat are blocked by intracerebroventricular injection of corticotropin-releasing factor antagonist.
    Lai H; Carino MA
    Brain Res; 1990 Sep; 527(2):354-8. PubMed ID: 2253041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential roles of corticotropin-releasing factor receptor subtypes 1 and 2 in opiate withdrawal and in relapse to opiate dependence.
    Lu L; Liu D; Ceng X; Ma L
    Eur J Neurosci; 2000 Dec; 12(12):4398-404. PubMed ID: 11122350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increase in cortical and midbrain tryptophan hydroxylase activity by intracerebroventricular administration of corticotropin releasing factor: block by adrenalectomy, by RU 38486 and by bilateral lesions to the central nucleus of the amygdala.
    Singh VB; Hao-Phan T; Corley KC; Boadle-Biber MC
    Neurochem Int; 1992 Jan; 20(1):81-92. PubMed ID: 1304322
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intracerebroventricular administration of corticotropin-releasing factor induces c-fos mRNA expression in brain regions related to stress responses: comparison with pattern of c-fos mRNA induction after stress.
    Imaki T; Shibasaki T; Hotta M; Demura H
    Brain Res; 1993 Jul; 616(1-2):114-25. PubMed ID: 8358602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thyrotropin-releasing factor-induced adrenocorticotropin secretion is mediated by corticotropin-releasing factor.
    Brown MR; Carver-Moore K; Gray TS; Rivier C
    Endocrinology; 1989 Nov; 125(5):2558-62. PubMed ID: 2551657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Corticotropin-releasing factor (CRF) induced anorexia is not influenced by a melanocortin 4 receptor blockage.
    Vergoni AV; Bertolini A; Wikberg JE; Schiöth HB
    Peptides; 1999; 20(4):509-13. PubMed ID: 10458522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of corticotropin-releasing factor in the anorexia induced by exercise.
    Rivest S; Richard D
    Brain Res Bull; 1990 Jul; 25(1):169-72. PubMed ID: 2207704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intracerebroventricular administration of corticotropin-releasing factor antagonist attenuates c-fos mRNA expression in the paraventricular nucleus after stress.
    Imaki T; Shibasaki T; Wang XQ; Demura H
    Neuroendocrinology; 1995 Apr; 61(4):445-52. PubMed ID: 7783858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Corticotropin releasing factor antagonist reduces ischemic hippocampal neuronal injury.
    Lyons MK; Anderson RE; Meyer FB
    Brain Res; 1991 Apr; 545(1-2):339-42. PubMed ID: 1860056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reversal of stress- and CRF-induced anorexia in rats by the synthetic nociceptin/orphanin FQ receptor agonist, Ro 64-6198.
    Ciccocioppo R; Biondini M; Antonelli L; Wichmann J; Jenck F; Massi M
    Psychopharmacology (Berl); 2002 May; 161(2):113-9. PubMed ID: 11981590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of urocortin 2 and 3 on motor activity and food intake in rats.
    Ohata H; Shibasaki T
    Peptides; 2004 Oct; 25(10):1703-9. PubMed ID: 15476937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CRF antagonist partially reverses CRF- and stress-induced effects on feeding.
    Krahn DD; Gosnell BA; Grace M; Levine AS
    Brain Res Bull; 1986 Sep; 17(3):285-9. PubMed ID: 3490298
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Corticotropin-releasing factor antagonist attenuates the "anxiogenic-like" effect in the defensive burying paradigm but not in the elevated plus-maze following chronic cocaine in rats.
    Basso AM; Spina M; Rivier J; Vale W; Koob GF
    Psychopharmacology (Berl); 1999 Jul; 145(1):21-30. PubMed ID: 10445369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of alpha-helical-CRF[9-41] on feeding in goldfish: involvement of cortisol and catecholamines.
    de Pedro N; Alonso-Gómez AL; Gancedo B; Valenciano AI; Delgado MJ; Alonso-Bedate M
    Behav Neurosci; 1997 Apr; 111(2):398-403. PubMed ID: 9106678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure-related effects of CRF and CRF-derived peptides: dissociation of behavioral, endocrine and autonomic activity.
    Diamant M; de Wied D
    Neuroendocrinology; 1993 Jun; 57(6):1071-81. PubMed ID: 8232765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.